Ricin

• Countermeasures

Soligenix invited to NORD conference to present preliminary Dusquetide, RiVax results

Soligenix, Inc. was invited to the National Organization for Rare Disorders’ (NORD) Rare Diseases and Orphan Products Breakthrough Summit on…

Soligenix receives additional funds from NIAID for development of heat-stable ricin vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) on Friday exercised an option for RiVax, Soligenix, Inc.’s new heat-stable…

• Biological
• Countermeasures
• Government
• Private
• Research
• Threats

NIAID exercises option for RiVax

Soligenix, Inc., announced on Wednesday that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to…